Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1998 | 1 |
2005 | 1 |
2006 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies.
J Med Genet. 2005 Jul;42(7):602-3. doi: 10.1136/jmg.2004.024133.
J Med Genet. 2005.
PMID: 15994883
Free PMC article.
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.
Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M, Kim-Sing C, Olsson H, Ainsworth P, Eisen A, Saal H, Friedman E, Olopade O, Osborne M, Weitzel J, Lynch H, Ghadirian P, Lubinski J, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group.
Gronwald J, et al.
Int J Cancer. 2006 May 1;118(9):2281-4. doi: 10.1002/ijc.21536.
Int J Cancer. 2006.
PMID: 16331614
Free article.
Item in Clipboard
Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.
Narod SA, Risch H, Moslehi R, Dørum A, Neuhausen S, Olsson H, Provencher D, Radice P, Evans G, Bishop S, Brunet JS, Ponder BA.
Narod SA, et al.
N Engl J Med. 1998 Aug 13;339(7):424-8. doi: 10.1056/NEJM199808133390702.
N Engl J Med. 1998.
PMID: 9700175
Free article.
Item in Clipboard
Cite
Cite